Next Article in Journal
AC-ModNet: Molecular Reverse Design Network Based on Attribute Classification
Next Article in Special Issue
Severe Hypothermia Induces Ferroptosis in Cerebral Cortical Nerve Cells
Previous Article in Journal
Mitochondrial Elongation and ROS-Mediated Apoptosis in Prostate Cancer Cells under Therapy with Apalutamide and Complex I Inhibitor
Previous Article in Special Issue
Annulus Fibrosus Injury Induces Acute Neuroinflammation and Chronic Glial Response in Dorsal Root Ganglion and Spinal Cord—An In Vivo Rat Discogenic Pain Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 25
Issue 13
10.3390/ijms25136941
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparison of the Influence of Bisphenol A and Bisphenol S on the Enteric Nervous System of the Mouse Jejunum

by
Krystyna Makowska
1,* and
Sławomir Gonkowski
2
1
Department of Clinical Diagnostics, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 14, 10-957 Olsztyn, Poland
2
Department of Clinical Physiology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-957 Olsztyn, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(13), 6941; https://doi.org/10.3390/ijms25136941
Submission received: 26 April 2024 / Revised: 20 June 2024 / Accepted: 21 June 2024 / Published: 25 June 2024
(This article belongs to the Special Issue Recent Molecular Research of Neuroscience: Application of Animal Models)
Browse Figures
Versions Notes

Abstract

:
Bisphenols are dangerous endocrine disruptors that pollute the environment. Due to their chemical properties, they are globally used to produce plastics. Structural similarities to oestrogen allow bisphenols to bind to oestrogen receptors and affect internal body systems. Most commonly used in the plastic industry is bisphenol A (BPA), which also has negative effects on the nervous, immune, endocrine, and cardiovascular systems. A popular analogue of BPA-bisphenol S (BPS) also seems to have harmful effects similar to BPA on living organisms. Therefore, with the use of double immunofluorescence labelling, this study aimed to compare the effect of BPA and BPS on the enteric nervous system (ENS) in mouse jejunum. The study showed that both studied toxins impact the number of nerve cells immunoreactive to substance P (SP), galanin (GAL), vasoactive intestinal polypeptide (VIP), the neuronal isoform of nitric oxide synthase (nNOS), and vesicular acetylcholine transporter (VAChT). The observed changes were similar in the case of both tested bisphenols. However, the influence of BPA showed stronger changes in neurochemical coding. The results also showed that long-term exposure to BPS significantly affects the ENS.

1. Introduction

Human and animal exposure to environmental pollutants has significantly increased with the development of global industry. Endocrine disruptors like bisphenol A (BPA) are particularly dangerous. BPA is widely used in the production of plastic because of its chemical properties, including high endurance over a broad range of temperatures (−40 to 145 °C) and hardness [1].
However, due to its similarities to oestrogen, BPA can bind to oestrogen receptors and affect internal body systems [2]. In previous studies, exposure to BPA has been linked to obesity, thyroid malfunction, and lipid and glucose homeostasis alterations [3]. Moreover, BPA has also been documented to have negative effects on female and male reproductive function and the potential to interact with DNA even at low doses. This chemical may also interfere with cell division, leading to disorders including carcinogenesis [4]. As a result, BPA has been considered one of the most prevalent and harmful endocrine disruptors, which, even in relatively low doses, negatively affects living organisms [5]. Therefore, its use in industry has been restricted, and many countries have decided to withdraw BPA from the production of plastic equipment for babies [6,7,8]. Instead of bisphenol A, its analogues are increasingly used in the production of plastics. One of the most commonly used BPA analogues is bisphenol S (BPS).
When introduced, BPS was considered a harmless replacement for BPA. However, with increasing research, the knowledge about its harmful and similar BPA effects on living organisms has expanded [9,10]. It is known that BPS, like BPA, can impact the endocrine system, resulting in disturbances in reproduction, obesity, hypertension, and other disorders [11,12,13]. Moreover, this substance can cause carcinogenic effects, as well as neuro-, cyto-, and genotoxicity [10,14]. Furthermore, it has been mentioned that the oestrogenic activity of BPS may be even more advanced than that caused by BPA [9].
Despite the amount of research concerning the influence of bisphenols on living organisms, their impact on the gastrointestinal (GI) tract and the enteric nervous system (ENS) is still not fully known.
The organisation of the ENS, which regulates most functions of the GI tract and is localised in the wall of the oesophagus, stomach, and intestine, depends on the segment of the GI tract and the animal species. In the wall of the rodent small intestine, it is formed from two ganglionated plexuses—the submucous plexus (SmP), which is located in the submucosal layer in close proximity to the mucosa, and the myenteric plexus (MP), situated between the circular and longitudinal muscle layers [15].
Changes in the enteric neurons under physiological and pathological factors can be morphological, electrophysiological, or functional. This modification ability is known as the plasticity of neurons and may be an organism’s first adaptive or protective reaction to disorders of homeostasis caused by pathological and toxic stimuli [16]. The most visible changes in the ENS concern the neurochemical characterisation of neurons, i.e., the ability to produce and secrete active substances performing functions of neurotransmitters or neuromodulators [16,17,18]. Until now, several tens of active substances have been described in the ENS [19]. The most important of these are the following: acetylcholine, vasoactive intestinal polypeptide (VIP), nitric oxide, substance P (SP), and galanin (GAL) [17,20].
It should be underlined that choosing jejunum for the present investigation was not accidental. It is known that the small intestine is the longest section of the digestive tract, and intestinal villi also make it the largest absorptive surface in the whole gastrointestinal system. This is where the main part of digestion takes place, and from the wall of this organ, large amounts of mucus and intestinal juice are secreted [21]. Moreover, the small intestine is where bisphenols in food are absorbed and metabolised [22,23].
Considering the above, the present study aimed to investigate and compare for the first time the influence of BPA and BPS on the jejunal population of the enteric neurons containing selected active substances playing important functions in the regulation of GI tract activity, including VIP, the neuronal isoform of nitric oxide synthase (nNOS), which is a marker of nitrergic neurons, vesicular acetylcholine transporter (VAChT), which is a marker of cholinergic neurons, SP and GAL.

2. Results

During the present study, no clinical signs were observed in animals receiving BPA or BPS. There were also no differences in behaviour or amount of feed consumed. However, double-labelling immunohistochemistry revealed that all neuronal factors studied were present in neurons in both submucous and myenteric plexuses of mouse jejunum. Partial results obtained in the experiment are presented in Table 1.
In physiological conditions, the most numerous population consists of neurons containing VAChT. The percentage of such neurons amounted to 53.50 ± 1.63% and 49.11 ± 1.35% of all PGP 9.5-positive cells in the MP and SmP, respectively. A slightly smaller population (approximately one-third of cells immunoreactive to PGP 9.5) consisted of neurons containing nNOS and/or VIP. In particular, nNOS was found in 37.25 ± 1.28% of cells in the MP and 29.53 ± 0.37% in the SmP. In the case of VIP, these values amounted to 30.56 ± 1.77% and 29.59 ± 0.42% in the MP and SmP, respectively. Neurons immunoreactive to GAL and/or SP were less numerous. GAL was found in 25.54 ± 0.89% of all PGP 9.5-positive cells in the MP and 20.16 ± 0.92% in the SmP. In turn, the percentage of neurons immunoreactive to SP amounted to 17.16 ± 1.07% and 19.32 ± 0.53% in the MP and SmP, respectively (Table 2, Figure 1, Figure 2 and Figure 3).
During the present experiment, changes in the immunoreactivity of enteric neurons were observed in the case of both types of intramural plexuses after the administration of both bisphenols. Generally, those changes consisted of an increase in the number of cells containing nNOS, VIP, GAL, and/or SP with a simultaneous decrease in VAChT+ neurons. The observed changes depended on the type of bisphenol and its dose, and more visible fluctuations were noted in animals treated with BPA (Table 2, Figure 1, Figure 2 and Figure 3).
In the MP, the most visible BPA-induced changes were noted in the neurons that were immunoreactive to VIP. The percentage of such neurons in animals treated with a lower dose of BPA amounted to 40.66 ± 0.92% of all PGP 9.5-positive cells (increase by approx. 10 percentage points (pp) compared to the control animals, and in animals treated with a higher dose of BPA, the percentage reached 45.52 ± 2.39% (an increase of approx. 15 pp)). Slightly smaller changes were observed in the case of neurons containing nNOS and/or GAL. In animals of the BPA1 group, the percentage of nNOS-positive neurons was 42.74 ± 1.42% (an increase of approx. 5 pp), and in animals of the BPA2 group, it was 47.21 ± 3.67% (an increase of approx. 10 pp). For GAL-positive neurons, these values amounted to 29.31 ± 1.06% (an increase of approximately 4 pp) and 35.08 ± 1.36 (an increase of approximately 10 pp) in BPA1 and BPA2 groups, respectively. In the MP, BPA also caused an increase in the percentage of neurons containing SP to 20.00 ± 0.58% (an increase of approx. 3 pp) in the case of lower doses and to 30.38 ± 1.93% (an increase of approx. 13 pp) in the case of higher doses (Table 2, Figure 2).
In the SmP, the most visible BPA-induced changes are in the increase in the percentage of neuron-concerned cells immunoreactive to VIP and/or GAL. In the BPA1 group, the percentage of VIP-positive cells amounted to 34.98 ± 0.62% (an increase of approx. 5 pp in comparison to the control animals) and in the BPA2 group to 39.81 ± 2.43% (an increase of approx. 10 pp). In turn, a lower dose of BPA caused an increase in GAL-positive cells to 29.31 ± 1.06% of all PGP 9.5-positive cells (an increase of approx. 6 pp) and higher doses of BPA to 29.32 ± 0.96% (an increase of approx. 9 pp). In the SmP, BPA-induced increases in the percentage of neurons containing nNOS and/or SP were also noted. In animals of the BPA1 group, the percentage of nNOS-positive cells amounted to 32.65 ± 0.82% (an increase of approx. 3 pp), and in animals of the BPA2 group to 39.52 ± 1.29% (an increase of approx. 10 pp). In the case of SP-positive neurons, these values achieved 23.31 ± 0.55% (an increase of approx. 4 pp) and 27.28 ± 1.42% (an increase of approx. 8 pp), respectively.
Contrary to other neuronal populations, BPA caused a decrease in the percentage of neurons containing VAChT, both in the MP and SmP. In the MP, the percentage of such neurons amounted to 46.74 ± 1.98% of all PGP 9.5-positive cells (decrease by approx. 7 pp in the comparison of the control animals) in the BPA1 group and 41.10 ± 1.62% (decrease by approx. 10 pp) in BPA2 group. Similar changes were noted in the SmP, where the lower dose of BPA caused a decrease in the percentage of VAChT-positive neurons to 42.88 ± 1.27% (by approx. 7 pp) and higher doses of this substance to 38.94 ± 1.65% (by approx. 11 pp).
As mentioned above, changes noted under the impact of BPS were generally less visible. Both doses of BPS studied caused an increase in the percentage of cells immunoreactive to nNOS and/or SP, both in the MP and SmP. In the BPS1 group, the percentage of neurons containing nNOS amounted to 40.28 ± 0.53% in the MP (an increase of approx. 3 pp in comparison to the control animals) and 34.70 ± 0.58% in the SmP (an increase of approx. 5 pp). In the case of SP-positive neurons, these values achieved 20.15 ± 0.84% (an increase of approx. 3 pp) and 21.15 ± 0.53% (an increase of approx. 2 pp) in the MP and SmP, respectively. In animals treated with lower doses of BPS, statistically significant changes in the percentage of neurons immunoreactive to VIP and/or GAL compared to the control animal were not observed (Table 2, Figure 1 and Figure 3).
The higher doses of BPS caused an increase in the percentage of neurons containing nNOS, VIP, GAL, and/or SP in both types of enteric plexuses. In the MP, the most visible changes concerned neurons that were immunoreactive to VIP and nNOS. The percentage of VIP-positive neurons increased to 39.98 ± 1.06% of all PGP 9.5-positive cells (an increase of approx. 9 pp in comparison to the control animals), and the percentage of neurons immunoreactive to nNOS increased to 45.03 ± 1.54% (by approx. 8 pp). The percentage of neurons containing SP and/or GAL amounted to 24.70 ± 0.68% (an increase of approx. 7 pp) and 31.50 ± 1.64% (an increase of approx. 6 pp), respectively. Changes noted in the SmP under the impact of higher doses of BPS were less visible than those observed in the MP. The percentage of nNOS-positive neurons achieved 37.62 ± 0.99% (an increase of approx. 8 pp in comparison to the control animals), VIP-positive neurons 33.21 ± 0.8% (an increase of approx. 4 pp), GAL-positive neurons 24.27 ± 0.98% (an increase of approx. 4 pp), and SP-positive cells 22.50 ± 0.98% (an increase of approx. 3 pp) (Table 2, Figure 1 and Figure 3).
Moreover, similarly to BPA, BPS caused a decrease in the percentage of neurons containing VAChT. In animals treated with lower doses of BPA, the percentage of such neurons amounted to 49.00 ± 1.22% in the MP and 45.22 ± 1.01 in the SmP (in both types of the enteric plexuses, there is a decrease by approximately 4 pp in comparison to the control animals). In animals treated with higher doses of BPA, the changes were more visible. The percentage of VAChT-positive cells amounted 44.25 ± 1.01% and 40.36 ± 0.74% in the MP and SmP, respectively. These values were lower than those noted in the control animals by approximately 9 pp. The summarisation of the obtained results is presented in Table 1 and Table 2.

3. Discussion

The results obtained during the present experiment, showing relatively large populations of nNOS-, VIP-, GAL-, SP-, and/or VAChT-positive neurons in the intramural plexuses of jejunum, are consistent with previous studies concerning the ENS in different mammal species, including humans [24,25,26,27]. Therefore, the present results confirm the important roles of the factors mentioned above in regulating intestine functions. However, it should be highlighted that the ENS in mice jejunum is still not fully described in the scientific literature [28]. Obviously, the presence of the above-mentioned substances in this part of the nervous system in rodents has been the subject of many publications, but the particular populations of nerve cells immunoreactive to selected neuronal factors, especially when it comes to the submucous plexus, is an underexploited topic. Very often, in the case of this animal species, only the muscular plexus is the subject of research, although it is commonly known that neurons located in the submucous plexus also play a significant role, primarily in the regulation of adsorption and secretion of mucus and intestinal juice [29].
Moreover, the present study has shown a significant effect of BPA and BPS on the neurochemical characterisation of neurons in the ENS of the mice jejunum. In general, these observations are consistent with previous studies on the impact of toxic agents on the gastrointestinal tract and confirm the ability of intestinal neurons to change their neurochemical characteristics under the influence of toxic substances [30,31,32].
Both bisphenols studied have affected the population of nNOS-, GAL-, VIP-, SP-, and/or VAChT-positive neurons; however, the intensification of changes depended on the examined plexus and the type and dose of bisphenol.
BPA- and BPS-induced decrease in the number of cholinergic neurons was noted in the present study. Similar observations have been described in previous studies concerning the autonomic nervous system of other organs under the impact of BPA [33,34,35]. Moreover, similar changes have been previously noted as a result of various pathological and toxic stimuli in other parts of the gastrointestinal tract [30,31,32], which can imply blocking of the synthesis of acetylcholine during pathological conditions. This, in turn, suggests that acetylcholine, which is the most important neurotransmitter within the ENS in physiological conditions, loses its significance during processes occurring under the impact of pathological stimuli. Moreover, it is commonly known that acetylcholine is the main neuronal factor which increases intestinal motility [28,36]. Therefore, the decrease in the number of enteric cholinergic neurons noted under the impact of bisphenols, both in the present study and previous investigations [20,37], may be connected to the relatively well-known relaxant effect of BPA within the gastrointestinal tract [38]. On the other hand, the decrease in the number of cholinergic nerve structures in the wall of the gastrointestinal tract may be related to the direct effect of BPA on the nervous system and the neurotoxic effect of this substance, manifested by impaired development and function of synapses, as well as changes in neuroprotein expression and ion transport [39,40,41,42].
The obtained results have shown that the number of neurons immunoreactive to other neuronal factors studied increases under the impact of bisphenol A and S. This observation is in agreement with previous studies, in which the increase in the number of GAL-, SP-, VIP-, and/or nNOS-positive enteric neurons has been found under the impact of various pathological and toxic stimuli [30,31]. It is probably connected with the functions of the above-mentioned neuronal substances in the intestine, and therefore, a brief reminder of them seems justified.
It is well known that GAL plays a trophic role in the nervous system and protects neurons during neurodegenerative diseases such as Alzheimer’s and Parkinson’s [43]. In the gastrointestinal tract, in addition to neuroprotective properties [44,45], GAL regulates secretion, motility, blood flow, and immunological processes [30,46,47,48]. Therefore, the observed fluctuations in the number of GAL+ neurons may also be the result of BPA-induced disturbances in the functioning of the intestinal barrier, which has been described in previous investigations [25,37].
In turn, SP is mainly involved in the immunological reactions [49] and adaptive and protective processes taking place in the nervous tissue [50]. Therefore, the increase in the number of SP-immunoreactive neurons may result from the impact of bisphenols on the immune system and their relatively well-known pro-inflammatory activity. Although it is known that BPA not only affects the gastrointestinal mucosa, leading to increased apoptosis, inhibition of mucin secretion, and disruption of the intestinal barrier, it also causes an increase in the expression of pro-inflammatory cytokines [51]. On the other hand, SP is a key pro-inflammatory substance that has many important functions in the activation of the immune system, leading to an increase in the synthesis and expression of tumour necrosis factor-alpha and interleukins, including IL-1 and IL-6 [49]. Moreover, SP is involved in the regulation of intestinal motility [52], and the increase in the number of SP-positive cells under the impact of bisphenols may be the adaptive answer of the ENS on the decrease in the percentage of cholinergic neurons.
The next enteric neuronal populations included in this study are vipergic and nitrergic cells, which play various functions in the intestine. First of all, VIP and nitric oxide are the main inhibitory factors that cause the relaxation of intestinal smooth muscles [39]. Both VIP and NO are also antioxidants and factors that inhibit the secretion of the gastrointestinal tract [19,53]. In addition, these substances influence the intestinal blood flow, may affect immune reactions, and have relatively strong anti-inflammatory and neuroprotective properties [54,55,56,57]. Therefore, the increase in the number of VIP- and/or nNOS-immunoreactive neurons noted during the present study is probably related to the participation of these substances in adaptive and/or protective mechanisms occurring during exposure to bisphenols, as well as bisphenol-induced changes in the intestinal motility and proinflammatory activity of them.
In the case of BPS, similar changes were observed under the influence of a higher dose of this toxin. This may suggest that BPS is less toxic than BPA, but at a higher dose, it affects the organism in a way that is similar to BPA.
It should be noted that the impact of bisphenols on the digestive tract is multidirectional. These substances show not only neurotoxic and proinflammatory properties [51] and, as mentioned above, impair intestinal motility [58], but also the intestinal microbiome [59], which, in turn, may result in an increased risk of systemic toxicity [60]. It is also known that most colon diseases, such as ulcerative colitis, cancer, and aganglionosis, are accompanied by colonic motility disorders that may result from exposure to bisphenols [58,61,62]. This is confirmed by previous studies that showed a correlation between the severity of exposure to BPA and some pathological processes in the descending colon [63]. It should be emphasised that BPA not only affects the motility of the gastrointestinal tract but also increases the permeability of the mucosa by damaging the intestinal barrier [59], and also induces apoptosis and mitochondrial dysfunction in the gastro-intestinal mucosa layer, which is associated with BPA-induced oxidative stress and inflammatory processes [59,61]. All the effects of exposure to bisphenols mentioned above may be reflected in the changes in the neurochemical characteristics of enteric neurons observed in this study.
Moreover, the present study has shown that BPS has similar effects on the enteric neurons as BPA. This confirms previous studies that found that BPS is not safe for living organisms [3,10]. However, contrary to previous observations, which have described that BPS may have a stronger toxic effect than BPA [9], changes observed in the present study under the impact of BPS were visibly less severe than those noted under the impact of BPA. This may suggest that BPS (especially in lower doses) affects the ENS to a lesser extent than BPA.
Of course, the present study has some limitations. The most important of them is the fact that the immunofluorescence technique allows for changes in the number of neurons immunoreactive to particular substances occurring under the influence of BPA and BPS, but it does not explain the mechanisms underlying these changes. Therefore, further comprehensive research is necessary to elucidate all aspects of the effect of bisphenols on the ENS.

4. Material and Methods

To achieve the aim of the study, 35 CD1 strain mice (three months old at the start of the experiment, both genders) were used. The animals were divided into five groups (seven animals in each) according to the following scheme: C (control)—animals were not treated with bisphenols; BPA1—animals were treated with BPA in the dose of 5 mg/kg b.w./day; BPA2—animals received BPA at 50 mg/kg b.w./day; BPS1—animals were treated with BPS at 5 mg/kg b.w./day; and BPS2—animals received BPS at 50 mg/kg b.w./day.
The choice of the above-mentioned doses of bisphenols was because, based on previous studies, a BPA dose of 5 mg/kg b.w. has been described as a systemic no-observed-adverse-effect level (NOAEL) dose of this substance in CD1 mouse, and the dose of 50 mg/kg b.w. is a lowest-observed-adverse-effect level (LOAEL) dose for BPA in mouse [64,65,66].
All animals were kept under standard laboratory conditions, and bisphenols were given for three months in drinking water following the technique previously described by Makowska et al. 2023 [33]. All experimental procedures have been performed according to the approval of the Local Ethical Committee on the Experimental Animals in Olsztyn (Decision Nº 46/2019).
Immediately after euthanasia (by decapitation), 2 cm long parts of the jejunum (from the place located approx. 15 cm behind the stomach) were taken from every animal. Fragments of the intestine were put into 4% paraformaldehyde solution and fixed overnight. For three days, intestinal fragments were rinsed (at 4 °C) with everyday exchange of phosphate buffer (0.1 M, pH 7.4) and then put into 18% phosphate-buffered sucrose solution for at least three weeks at 4 °C.
Such prepared tissues were frozen at −20 °C, cut into 12 μm thick sections using a microtome (Microm, HM 525, Walldorf, Germany) and fixed on the microscopic slides. Intestinal sections were then subjected to the routine double immunofluorescence technique described previously by Wojtkiewicz et al. 2017 [67]. This method consists of several steps, as shown in Figure 4.
For the double immunofluorescence staining, commercial antibodies directed against protein gene product 9.5 (PGP 9.5—used here as a pan-neuronal marker), vasoactive intestinal polypeptide (VIP), galanin (GAL), substance P (SP), the neuronal isoform of nitric oxide synthase (nNOS—used as a marker of nitrergic markers), and vesicular acetylcholine transporter (VAChT—used as a marker of cholinergic neurons) were used. The exact specification of primary and secondary antibodies is presented in Table 3.
To exclude non-specific labelling, typical specificity tests (including pre-absorption of the antibodies with appropriate antigens and omission and replacement tests) were performed. Labelled tissues were evaluated with an epi-fluorescence microscope (Olympus, BX51), and the photographic documentation was made using a digital camera connected to a PC and processed with Olympus Cell F image analysis software version 1.17 (Olympus, Tokyo, Japan).
In determining the percentage of neurons immunoreactive to particular neuronal active substances, about 500 PGP 9.5-positive cells in each type of enteric plexus were assessed for each neuronal factor included in the study. The evaluation included only neurons with a visible cell nucleus, and the population of PGP 9.5 neurons was considered 100%. The obtained data were presented as the mean value ± SEM. In order to avoid double counting of the same cells, the sections evaluated were spaced at least 150 μm apart.
A statistical analysis of the obtained results was carried out with a one-way analysis of variance (ANOVA) with Dunnett’s test using Statistica 12 software (StatSoft Inc., Tulsa, OK, USA). Differences between studied groups were considered statistically significant at p < 0.05.

5. Conclusions

The present study is the first description of the influence of BPA and BPS administered in the same doses on the ENS in the mouse jejunum. The results show that the relatively low doses of both bisphenols used in the experiment do not cause any clinical symptoms but clearly influence the neurochemical characterisation of the enteric neurons. Therefore, changes observed in the ENS may be the first signs of the toxic activity of bisphenols and simultaneously the first answer of the gastrointestinal tract to exposure to these substances.
Comparing the influence of lower doses of BPA and BPS on the ENS, it has been found that BPA causes much more pronounced changes in the neurochemical characterisation of the enteric neurons, which might suggest that BPS is characterised by less toxicity and endocrine-disrupting activity than BPA. However, comparing the impact of higher doses of BPA and BPA, it has been proven that the administration of both bisphenols results in similar changes in the neurochemical characterisation of the enteric neurons. The observed similarities in the effects of BPA and BPS probably result from a similar chemical structure, as well as the similar endocrine-disrupting, pro-inflammatory, and neurotoxic properties of these substances.
The results have shown that although low doses of BPS affect the ENS to a lesser extent than BPA, this substance is not neutral for the nervous system supplying the GI tract, and exposure to it may result in changes in levels of neuronal active substances.
It should also be underlined that due to the multidirectional effects of bisphenols on the intestine and nervous system, the exact mechanisms of observed changes still remain unknown, and understanding these mechanisms requires further comprehensive research.

Author Contributions

Conceptualization, K.M. and S.G.; Data curation, K.M. and S.G.; Formal analysis, K.M.; Funding acquisition, K.M.; Investigation, K.M. and S.G.; Methodology, K.M.; Supervision, S.G.; Visualization, K.M.; Writing—original draft, K.M. and S.G.; Writing—review and editing, K.M. and S.G. All authors have read and agreed to the published version of the manuscript.

Funding

Publication funded by the Minister of Science under the Regional Initiative of Excellence Program and National Science Centre in Poland (Grant No. 2018/31/N/NZ7/01252).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  1. Mikolajewska, K.; Stragierowicz, J.; Gromadzinska, J. Bisphenol A—Application, sources of exposure and potential risks in infants, children and pregnant women. Int. J. Occup. Med. Environ. Health 2015, 28, 209–241. [Google Scholar] [CrossRef] [PubMed]
  2. Rubin, B.S. Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects. J. Steroid. Biochem. Mol. Biol. 2011, 127, 27–34. [Google Scholar] [CrossRef] [PubMed]
  3. Meng, Z.; Wang, D.; Yan, S.; Li, R.; Yan, J.; Teng, M.; Zhou, Z.; Zhu, W. Effects of perinatal exposure to BPA and its alternatives (BPS, BPF and BPAF) on hepatic lipid and glucose homeostasis in female mice adolescent offspring. Chemosphere 2018, 212, 297–306. [Google Scholar] [CrossRef] [PubMed]
  4. Adeyi, A.A. Distribution and bioaccumulation of Endocrine Disrupting Chemicals (EDCS) in Lagos Lagoon water, sediment and fish. Ife J. Sci. 2020, 22, 57–74. [Google Scholar] [CrossRef]
  5. Pivnenko, K.; Pedersen, G.A.; Eriksson, E.; Astrup, T.F. Bisphenol A and its structural analogues in household waste paper. Waste Manag. 2015, 44, 39–47. [Google Scholar] [CrossRef] [PubMed]
  6. Almeida, S.; Raposo, A.; Almeida-Gonzales, M.; Carrascosa, C. Bisphenol A: Food exposure and impact on human health. Compr. Rev. Food Sci. Food Saf. 2018, 17, 1503–1517. [Google Scholar] [CrossRef] [PubMed]
  7. Michałowicz, J. Bisphenol A—Sources, toxicity and biotransformation. Environ. Toxicol. Pharmacol. 2014, 37, 738–758. [Google Scholar] [CrossRef] [PubMed]
  8. Frankowski, R.; Zgoła-Grześkowiak, A.; Grześkowiak, T.; Sójka, K. The presence of bisphenol A in the thermal paper in the face of changing European regulations–A comparative global research. Environ. Pollut. 2020, 265, 114879. [Google Scholar] [CrossRef]
  9. Thoene, M.; Dzika, E.; Gonkowski, S.; Wojtkiewicz, J. Bisphenol S in food causes hormonal and obesogenic effects comparable to or worse than bisphenol A: A literature review. Nutrients 2020, 12, 532. [Google Scholar] [CrossRef]
  10. Winkler, J.; Liu, P.; Phong, K.; Hinrichs, J.H.; Ataii, N.; Williams, K.; Hadler-Olsen, E.; Samson, S.; Gartner, Z.J.; Fisher, S.; et al. Bisphenol A replacement chemicals, BPF and BPS, induce protumorigenic changes in human mammary gland organoid morphology and proteome. Proc. Natl. Acad. Sci. USA 2022, 119, e2115308119. [Google Scholar] [CrossRef]
  11. Rochester, J.R.; Bolden, A.L. Bisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A Substitutes. Environ. Health Perspect. 2015, 123, 643–650. [Google Scholar] [CrossRef] [PubMed]
  12. Fouyet, S.; Olivier, E.; Leproux, P.; Dutot, M.; Rat, P. Bisphenol A, Bisphenol F, and Bisphenol S: The Bad and the Ugly. Where Is the Good? Life 2021, 11, 314. [Google Scholar] [CrossRef] [PubMed]
  13. Xiao, X.; Zhang, X.; Bai, J.; Li, J.; Zhang, C.; Zhao, Y.; Zhu, Y.; Zhang, J.; Zhou, X. Bisphenol S increases the obesogenic effects of a high-glucose diet through regulating lipid metabolism in Caenorhabditis elegans. Food Chem. 2021, 339, 127813. [Google Scholar] [CrossRef]
  14. Qiu, W.; Chen, B.; Greer, J.B.; Magnuson, J.T.; Xiong, Y.; Zhong, H.; Andrzejczyk, N.E.; Zheng, C.; Schlenk, D. Transcriptomic Responses of Bisphenol S Predict Involvement of Immune Function in the Cardiotoxicity of Early Life-Stage Zebrafish (Danio rerio). Environ. Sci. Technol. 2020, 54, 2869–2877. [Google Scholar] [CrossRef] [PubMed]
  15. Hamnett, R.; Dershowitz, L.B.; Sampathkumar, V.; Wang, Z.; Gomez-Frittelli, J.; De Andrade, V.; Kasthuri, N.; Druckmann, S.; Kaltschmidt, J.A. Regional cytoarchitecture of the adult and developing mouse enteric nervous system. Curr Biol. 2022, 32, 4483–4492.e5. [Google Scholar] [CrossRef] [PubMed]
  16. Vasina, V.; Barbara, G.; Talamonti, L.; Stanghellini, V.; Corinaldesi, R.; Tonini, M.; De Ponti, F.; De Giorgio, R. Enteric neuroplasticity evoked by inflammation. Auton. Neurosci. 2006, 126–127, 264–272. [Google Scholar] [CrossRef] [PubMed]
  17. Furness, J.B. The enteric nervous system and neurogastroenterology. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 286–294. [Google Scholar] [CrossRef] [PubMed]
  18. Lefèvre, C.; Bessard, A.; Aubert, P.; Joussain, C.; Giuliano, F.; Behr-Roussel, D.; Perrouin-Verbe, M.A.; Perrouin-Verbe, B.; Brochard, C.; Neunlist, M. Enteric Nervous System Remodeling in a Rat Model of Spinal Cord Injury: A Pilot Study. Neurotrauma Rep. 2020, 1, 125–136. [Google Scholar] [CrossRef] [PubMed]
  19. Furness, J.B.; Callaghan, B.P.; Rivera, L.R.; Cho, H.J. The enteric nervous system and gastrointestinal innervation: Integrated local and central control. Adv. Exp. Med. Biol. 2014, 817, 39–71. [Google Scholar]
  20. Timmermans, J.P.; Barbiers, M.; Scheuermann, D.W.; Stach, W.; Adriaensen, D.; Mayer, B.; De Groodt-Lasseel, M.H. Distribution pattern, neurochemical features and projections of nitrergic neurons in the pig small intestine. Ann Anat. 1994, 176, 515–525. [Google Scholar] [CrossRef]
  21. Volk, N.; Lacy, B. Anatomy and Physiology of the Small Bowel. Gastrointest. Endosc. Clin. N. Am. 2017, 27, 1–13. [Google Scholar] [CrossRef] [PubMed]
  22. Sakamoto, H.; Yokota, H.; Kibe, R.; Sayama, Y.; Yuasa, A. Excretion of bisphenol A-glucuronide into the small intestine and deconjugation in the cecum of the rat. Biochim. Biophys. Acta. 2002, 1573, 171–176. [Google Scholar] [CrossRef] [PubMed]
  23. Peillex, C.; Kerever, A.; Lachhab, A.; Pelletier, M. Bisphenol A, bisphenol S and their glucuronidated metabolites modulate glycolysis and functional responses of human neutrophils. Environ. Res. 2021, 196, 110336. [Google Scholar] [CrossRef]
  24. Rząp, D.; Czajkowska, M.; Całka, J. Neurochemical Plasticity of nNOS-, VIP- and CART-Immunoreactive Neurons Following Prolonged Acetylsalicylic Acid Supplementation in the Porcine Jejunum. Int. J. Mol. Sci. 2020, 21, 2157. [Google Scholar] [CrossRef]
  25. Szymanska, K.; Gonkowski, S. Neurochemical characterization of the enteric neurons within the porcine jejunum in physiological conditions and under the influence of bisphenol A (BPA). Neurogastroenterol. Motil. 2019, 31, e13580. [Google Scholar] [CrossRef] [PubMed]
  26. Serzysko, T.; Skwarek, A.; Chudziak, E.; Malina, M.; Kaleczyc, J.; Sienkiewicz, W. Enteric neuronal development in canine small intestine—An immunohistochemical study. Pol. J. Vet. Sci. 2021, 24, 293–301. [Google Scholar] [CrossRef]
  27. Schuy, J.; Schlabrakowski, A.; Neuhuber, W.; Brehmer, A. Quantitative estimation and chemical coding of spiny type I neurons in human intestines. Cells Tissues Organs 2011, 193, 195–206. [Google Scholar] [CrossRef]
  28. Spencer, N.J.; Hu, H. Enteric nervous system: Sensory transduction, neural circuits and gastrointestinal motility. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 338–351. [Google Scholar] [CrossRef]
  29. Herath, M.; Hosie, S.; Bornstein, J.C.; Franks, A.E.; Hill-Yardin, E.L. The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders. Front. Cell. Infect. Microbiol. 2020, 10, 248. [Google Scholar] [CrossRef]
  30. Palus, K.; Makowska, K.; Całka, J. Alterations in Galanin-Like Immunoreactivity in the Enteric Nervous System of the Porcine Stomach Following Acrylamide Supplementation. Int. J. Mol. Sci. 2019, 20, 3345. [Google Scholar] [CrossRef]
  31. Gonkowski, S.; Gajęcka, M.; Makowska, K. Mycotoxins and the Enteric Nervous System. Toxins 2020, 12, 461. [Google Scholar] [CrossRef] [PubMed]
  32. Palus, K.; Bulc, M.; Całka, J. Glyphosate affects the neurochemical phenotype of the intramural neurons in the duodenum in the pig. Neurogastroenterol. Motil. 2023, 35, e14507. [Google Scholar] [CrossRef] [PubMed]
  33. Makowska, K.; Lepiarczyk, E.; Gonkowski, S. The comparison of the influence of bisphenol A (BPA) and its analogue bisphenol S (BPS) on the enteric nervous system of the distal colon in mice. Nutrients 2023, 15, 200. [Google Scholar] [CrossRef] [PubMed]
  34. Makowska, K.; Lech, P.; Gonkowski, S. Bisphenol A Effects on Neurons’ Neurochemical Character in the Urinary Bladder Intramural Ganglia of Domestic Pigs. Int. J. Mol. Sci. 2023, 24, 16792. [Google Scholar] [CrossRef] [PubMed]
  35. Makowska, K.; Gonkowski, S. Changes Caused by Low Doses of Bisphenol A (BPA) in the Neuro-Chemistry of Nerves Located in the Porcine Heart. Animals 2021, 11, 780. [Google Scholar] [CrossRef] [PubMed]
  36. Li, Z.S.; Furness, J.B. Immunohistochemical localisation of cholinergic markers in putative intrinsic primary afferent neurons of the guinea-pig small intestine. Cell Tissue Res. 1998, 294, 35–43. [Google Scholar] [CrossRef] [PubMed]
  37. Makowska, K.; Gonkowski, S. Changes Caused by Bisphenols in the Chemical Coding of Neurons of the Enteric Nervous System of Mouse Stomach. Int. J. Environ. Res. Public Health 2023, 20, 5125. [Google Scholar] [CrossRef]
  38. Ambreen, S.; Akhtar, T.; Hameed, N.; Ashfaq, I.; Sheikh, N. In Vivo Evaluation of Histopathological Alterations and Trace Metals Estimation of the Small Intestine in Bisphenol A-Intoxicated Rats. Can. J. Gastroenterol. Hepatol. 2019, 2019, 9292316. [Google Scholar] [CrossRef]
  39. Xu, X.; Xie, L.; Hong, X.; Ruan, Q.; Lu, H.; Zhang, Q.; Zhang, G.; Liu, X. Perinatal exposure to bisphenol-A inhibits synaptogenesis and affects the synaptic morphological development in offspring male mice. Chemosphere 2013, 91, 1073–1081. [Google Scholar] [CrossRef] [PubMed]
  40. Szymanska, K.; Makowska, K.; Gonkowski, S. The Influence of High and Low Doses of Bisphenol A (BPA) on the Enteric Nervous System of the Porcine Ileum. Int. J. Mol. Sci. 2018, 19, 917. [Google Scholar] [CrossRef]
  41. Wright, E.C.; Johnson, S.A.; Hao, R.; Kowalczyk, A.S.; Greenberg, G.D.; Ordoñes Sanchez, E.; Laman-Maharg, A.; Trainor, B.C.; Rosenfeld, C.S. Exposure to extrinsic stressors, social defeat or bisphenol A, eliminates sex differences in DNA methyltransferase expression in the amygdala. J. Neuroendocrinol. 2017, 29, 10. [Google Scholar] [CrossRef] [PubMed]
  42. Mokra, K.; Kocia, M.; Michałowicz, J. Bisphenol A and its analogs exhibit different apoptotic potential in peripheral blood mononuclear cells (in vitro study). Food Chem. Toxicol. 2015, 84, 79–88. [Google Scholar] [CrossRef] [PubMed]
  43. Fang, P.; Yu, M.; Wan, D.; Zhang, L.; Han, L.; Shen, Z.; Shi, M.; Zhu, Y.; Zhang, Z.; Bo, P. Regulatory effects of galanin system on development of several age-related chronic diseases. Exp. Gerontol. 2017, 95, 88–97. [Google Scholar] [CrossRef] [PubMed]
  44. Ding, X.; MacTavish, D.; Kar, S.; Jhamandas, J.H. Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol. Dis. 2006, 21, 413–420. [Google Scholar] [CrossRef] [PubMed]
  45. Raghavendra Rao, V.L.; Bowen, K.K.; Dhodda, V.K.; Song, G.; Franklin, J.L.; Gavva, N.R.; Dempsey, R.J. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J. Neurochem. 2002, 83, 1072–1086. [Google Scholar] [CrossRef] [PubMed]
  46. Piqueras, L.; Taché, Y.; Martinez, V. Galanin inhibits gastric acid secretion through a somatostatin-independent mechanism in mice. Peptides 2004, 25, 1287–1295. [Google Scholar] [CrossRef] [PubMed]
  47. Psichas, A.; Glass, L.L.; Sharp, S.J.; Reimann, F.; Gribble, F.M. Galanin inhibits GLP-1 and GIP secretion via the GAL1 receptor in enteroendocrine L and K cells. Br. J. Pharmacol. 2016, 173, 888–898. [Google Scholar] [CrossRef] [PubMed]
  48. Lang, R.; Gundlach, A.L.; Kofler, B. The galanin peptide family: Receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther. 2007, 115, 177–207. [Google Scholar] [CrossRef] [PubMed]
  49. Yamaguchi, K.; Yamazaki, S.; Kumakura, S.; Someya, A.; Iseki, M.; Inada, E.; Nagaoka, I. Yokukansan, a Japanese Herbal Medicine, suppresses Substance P-induced Production of Interleukin-6 and Interleukin-8 by Human U373 MG Glioblastoma Astrocytoma Cells. Endocr. Metab. Immune Disord. Drug Targets 2020, 20, 1073–1080. [Google Scholar] [CrossRef]
  50. Wang, S.Y.; Chen, L.; Xue, Y.; Xia, Y.J. Substance P prevents 1-methyl-4-phenylpyridinium-induced cytotoxicity through inhibition of apoptosis via neurokinin-1 receptors in MES23.5 cells. Mol. Med. Rep. 2015, 12, 8085–8092. [Google Scholar] [CrossRef]
  51. Ye, X.; Liu, Z.; Han, H.W.; Noh, J.Y.; Shen, Z.; Kim, D.M.; Wang, H.; Guo, H.; Ballard, J.; Golovko, A.; et al. Nutrient-Sensing Ghrelin Receptor in Macrophages Modulates Bisphenol A-Induced Intestinal Inflammation in Mice. Genes 2023, 14, 1455. [Google Scholar] [CrossRef] [PubMed]
  52. Zalecki, M. Gastric ulcer induced changes in substance P and Nk1, Nk2, Nk3 receptors expression in different stomach localizations with regard to intrinsic neuronal system. Histochem. Cell Biol. 2019, 151, 29–42. [Google Scholar] [CrossRef] [PubMed]
  53. Kasparek, M.S.; Fatima, J.; Iqbal, C.W.; Duenes, J.A.; Sarr, M.G. Long-term effects of extrinsic denervation on VIP and substance P innervation in circular muscle of rat jejunum. J. Gastrointest. Surg. 2007, 11, 1339–1350. [Google Scholar] [CrossRef] [PubMed]
  54. de Souza, F.R.O.; Ribeiro, F.M.; Lima, P.M.D. Implications of VIP and PACAP in Parkinson’s Disease: What do we Know So Far? Curr. Med. Chem. 2021, 28, 1703–1715. [Google Scholar] [CrossRef] [PubMed]
  55. Vota, D.; Aguero, M.; Grasso, E.; Hauk, V.; Gallino, L.; Soczewski, E.; Pérez Leirós, C.; Ramhorst, R. Progesterone and VIP cross-talk enhances phagocytosis and anti-inflammatory profile in trophoblast-derived cells. Mol. Cell Endocrinol. 2017, 443, 146–154. [Google Scholar] [CrossRef] [PubMed]
  56. Deng, Y.; Pan, L.; Qian, W. Associations between the severity of reflux esophagitis in children and changes in oxidative stress, serum inflammation, vasoactive intestinal peptide and motilin. Exp. Ther. Med. 2019, 18, 3509–3513. [Google Scholar] [CrossRef] [PubMed]
  57. Korkmaz, O.T.; Tunçel, N. Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson’s Disease. Curr. Pharm. Des. 2018, 24, 4693–4701. [Google Scholar] [CrossRef] [PubMed]
  58. Sarkar, K.; Tarafder, P.; Paul, G. Bisphenol A inhibits duodenal movement ex vivo of rat through nitric oxide-mediated soluble guanylyl cyclase and α-adrenergic signaling pathways. J. Appl. Toxicol. 2016, 36, 131–139. [Google Scholar] [CrossRef] [PubMed]
  59. Feng, L.; Chen, S.; Zhang, L.; Qu, W.; Chen, Z. Bisphenol A increases intestinal permeability through disrupting intestinal barrier function in mice. Environ. Pollut. 2019, 254, 112960. [Google Scholar] [CrossRef]
  60. Inoue, A.; Hayashi, S.; Aoyagi, K.; Nishigaki, M.; Sasaki, H.; Kiyama, R. A reporter gene assay for evaluation of tissue-specific responses to estrogens based on the differential use of promoters A to F of the human estrogen receptor alpha gene. J. Pharmacol. Toxicol. Methods 2002, 47, 129–135. [Google Scholar] [CrossRef]
  61. Wang, H.; Zhao, P.; Huang, Q.; Chi, Y.; Dong, S.; Fan, J. Bisphenol-A induces neurodegeneration through disturbance of intracellular calcium homeostasis in human embryonic stem cells-derived cortical neurons. Chemosphere 2019, 229, 618–630. [Google Scholar] [CrossRef] [PubMed]
  62. Jun, J.H.; Oh, J.E.; Shim, J.K.; Kwak, Y.L.; Cho, J.S. Effects of bisphenol A on the proliferation, migration, and tumor growth of colon cancer cells: In vitro and in vivo evaluation with mechanistic insights related to ERK and 5-HT3. Food Chem. Toxicol. 2021, 158, 112662. [Google Scholar] [CrossRef] [PubMed]
  63. Wang, Y.; Rui, M.; Nie, Y.; Lu, G. Influence of gastrointestinal tract on metabolism of bisphenol A as determined by in vitro simulated system. J. Hazard. Mater. 2018, 355, 111–118. [Google Scholar] [CrossRef] [PubMed]
  64. Tyl, R.W.; Myers, C.B.; Marr, M.C.; Thomas, B.F.; Keimowitz, A.R.; Brine, D.R.; Veselica, M.M.; Fail, P.A.; Chang, T.Y.; Seely, J.C.; et al. Three generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol. Sci. 2002, 68, 121–146. [Google Scholar] [CrossRef] [PubMed]
  65. Choi, C.W.; Jeong, J.Y.; Hwang, M.S.; Jung, K.K.; Lee, K.H.; Lee, H.M. Establishment of the korean tolerable daily intake of bisphenol a based on risk assessments by an expert committee. Toxicol. Res. 2010, 26, 285–291. [Google Scholar] [CrossRef]
  66. Zielinska, M.; Wojnowska-Baryla, I.; Cydzik-Kwiatkowska, A. Bisphenol A Removal from Water and Wastewater; Springer International Publishing: Berlin/Heidelberg, Germany, 2018; ISBN 978-3-319-92361-1. [Google Scholar]
  67. Wojtkiewicz, J.; Makowska, K.; Bejer-Olenska, E.; Gonkowski, S. Zinc Transporter 3 (Znt3) as an Active Substance in the Enteric Nervous System of the Porcine Esophagus. J. Mol. Neurosci. 2017, 61, 315–324. [Google Scholar] [CrossRef]
Ijms 25 06941 g001
Figure 1. Graphical comparison of the percentage points of nerve cells immunoreactive to protein gene product (PGP 9.5), used here as a pan-neuronal marker, and other studied neurotransmitters: neuronal isoform of nitric oxide synthase (nNOS), vasoactive intestinal polypeptide (VIP), galanin (GAL), vesicular acetylcholine transporter (VAChT), and substance P (SP) in submucous (SmP) and myenteric plexus (MP) of mice jejunum with individual data points of every studied animal between physiological conditions (C) and experimental groups: after the administration of low (BPA1) and high (BPA2) doses of BPA and low (BPS1) and high (BPS2) doses of BPS. Statistically significant differences between the control and experimental groups are marked with *.
Figure 1. Graphical comparison of the percentage points of nerve cells immunoreactive to protein gene product (PGP 9.5), used here as a pan-neuronal marker, and other studied neurotransmitters: neuronal isoform of nitric oxide synthase (nNOS), vasoactive intestinal polypeptide (VIP), galanin (GAL), vesicular acetylcholine transporter (VAChT), and substance P (SP) in submucous (SmP) and myenteric plexus (MP) of mice jejunum with individual data points of every studied animal between physiological conditions (C) and experimental groups: after the administration of low (BPA1) and high (BPA2) doses of BPA and low (BPS1) and high (BPS2) doses of BPS. Statistically significant differences between the control and experimental groups are marked with *.
Ijms 25 06941 g001
Ijms 25 06941 g002
Figure 2. Nerve cells immunoreactive to protein gene product (PGP 9.5), used here as a pan-neuronal marker, and other studied neurotransmitters: neuronal isoform of nitric oxide synthase (nNOS), substance P (SP), and galanin (GAL) in myenteric plexus of mice jejunum under physiological conditions (C), after the administration of low (BPA1) and high (BPA2) doses of BPA. Neurons positive for selected substances are marked with arrows.
Figure 2. Nerve cells immunoreactive to protein gene product (PGP 9.5), used here as a pan-neuronal marker, and other studied neurotransmitters: neuronal isoform of nitric oxide synthase (nNOS), substance P (SP), and galanin (GAL) in myenteric plexus of mice jejunum under physiological conditions (C), after the administration of low (BPA1) and high (BPA2) doses of BPA. Neurons positive for selected substances are marked with arrows.
Ijms 25 06941 g002
Ijms 25 06941 g003
Figure 3. Nerve cells immunoreactive to protein gene product (PGP 9.5), used here as a pan-neuronal marker, and other studied neurotransmitters: substance P (SP), neuronal isoform of nitric oxide synthase (nNOS), and vesicular acetylcholine transporter (VAChT) in the myenteric plexus of mice jejunum under the physiological condition (C), after administration of low (BPS1) and high (BPS2) doses of BPS. Neurons positive for selected substances are marked with arrows.
Figure 3. Nerve cells immunoreactive to protein gene product (PGP 9.5), used here as a pan-neuronal marker, and other studied neurotransmitters: substance P (SP), neuronal isoform of nitric oxide synthase (nNOS), and vesicular acetylcholine transporter (VAChT) in the myenteric plexus of mice jejunum under the physiological condition (C), after administration of low (BPS1) and high (BPS2) doses of BPS. Neurons positive for selected substances are marked with arrows.
Ijms 25 06941 g003
Ijms 25 06941 g004
Figure 4. The immunofluorescence method.
Figure 4. The immunofluorescence method.
Ijms 25 06941 g004
Table 1. Partial results obtained in the experiment.
Table 1. Partial results obtained in the experiment.
nNOS
GroupCBPA1BPA2BPS1BPS2
GanglionMPSmPMPSmPMPSmPMPSmPMPSmP
Animal 1A506/200498/141505/209508/174504/307475/167501/216503/178506/215500/194
B39.5328.3141.3934.2560.9135.1643.1135.3942.4938.8
Animal 2A502/185500/148505/250504/156504/285509/192502/200504/169503/206507/190
B36.8529.649.530.9556.5537.7239.8433.5340.9537.47
Animal 3A502/200502/147502/201508/174512/235503/194503/206502/178509/214505/199
B39.8429.2840.0434.2545.938.5740.9535.4642.0439.41
Animal 4A502/150498/147502/207502/164506/227500/190500/194500/176505/231500/199
B29.8828.3141.2432.6744.863838.835.245.7439.8
Animal 5A509/196498/150503/194505/135502/242502/201505/200503/185509/225502/200
B38.5130.1238.5730.348.2140.0439.636.7844.239.84
Animal 6A500/191503/152508/216501/17901/155502/207502/201500/160517/242502/174
B38.230.2242.5235.7330.9441.2440.043246.8134.66
Animal 7A509/193505/156512/235500/152501/216512/235507/201504/174504/269501/167
B37.9230.8945.930.443.1145.939.6534.5252.9833.33
TotalC37.25
± 1.28		29.53
± 0.37		42.74
± 1.42 *		32.65
± 0.82 *		47.21
± 3.67 *		39.52
± 1.29 *		40.28
± 0.53 *		34.70
± 0.58 *		45.03
± 1.54 *		37.62
± 0.99 *
VIP
Animal 1A503/115508/157506/215502/174501/268505/250500/160504/174502/226504/172
B22.8630.9142.4934.6653.4949.53234.5245.0234.13
Animal 2A500/134501/148503/206502/170503/194506/140508/164502/152499/200502/155
B26.829.5440.9533.8638.5727.6732.2830.2840.0830.88
Animal 3A503/178501/155502/201502/174502/200500/200504/169502/141506/196502/178
B35.3930.9440.0434.6639.844033.5328.0938.7435.46
Animal 4A501/179500/143502/207509/196502/200501/201507/161500/160506/208498/165
B35.7328.641.2438.5139.8440.1231.763241.1133.13
Animal 5A507/168498/150502/210509/171502/242507/206508/167500/150500/200507/174
B33.1430.1241.8333.648.2140.6332.87304034.32
Animal 6A502/147502/144498/177502/176504/267509/214498/150501/152485/190504/150
B29.2828.6935.5435.0652.9842.0430.1230.3439.1829.76
Animal 7A508/156498/141508/216504/174505/231509/197503/194504/156501/179500/174
B30.7128.3142.5234.5245.7438.738.5730.9535.7334.8
TotalC30.56
± 1.77		29.59
± 0.42		40.66
± 0.92 *		34.98
± 0.62 *		45.52
± 2.39 *		39.81
± 2.43 *		33.02
± 1.01		30.88
± 0.75		39.98
± 1.06 *		33.21
± 0.8 *
GAL
Animal 1A504/134500/110509/128509/114503/178500/143509/128509/122500/143500/120
B26.592225.1522.435.3928.625.1523.9728.624
Animal 2A500/125500/112502/141505/113502/200504/145502/141507/121498/150506/109
B2522.428.0922.3839.8428.7728.0923.8630.1221.54
Animal 3A502/144500/104504/156507/127502/150499/166500/134504/117500/176505/112
B28.6920.830.9525.0529.8833.2726.823.2135.222.18
Animal 4A498/141507/109508/174500/134506/159500/125500/128502/176503/185509/135
B28.3121.534.2526.831.422525.635.0636.7826.52
Animal 5A505/120487/101502/141504/141501/174498/150507/139487/101508/164504/141
B23.7620.7428.0927.9834.7330.1227.4220.7432.2827.98
Animal 6A501/118504/90504/148500/138502/178502/144502/141489/74504/169504/131
B23.5517.8629.3727.635.4628.6928.0915.1333.5325.99
Animal 7A498/114500/79502/147506/151507/197503/155504/156500/79500/120502/109
B22.8915.829.2829.8438.8630.8230.9515.82421.71
TotalC25.54
± 0.89		20.16
± 0.92		29.31
± 1.06 *		26.01
± 1.08 *		35.08
± 1.36 *		29.32
± 0.96 *		27.44
± 0.73		22.54
± 2.51		31.50
± 1.64 *		24.27
± 0.98 *
VAChT
Animal 1A500/250502/242500/242500/196514/241502/199504/269508/216503/235506/208
B5048.2148.439.246.8839.6452.9842.5246.7241.11
Animal 2A501/250610/286514/241501/218505/180503/217504/252512/235500/215500/194
B49.946.8846.8843.5135.6443.145045.94338.8
Animal 3A548/279548/279505/180503/215505/182510/200505/241506/227507/220507/190
B50.8650.8635.6442.7436.0439.2147.7244.8643.3937.47
Animal 4A504/285513/256500/246519/231503/194506/161504/216513/241501/216517/27
B56.5549.949.244.5138.5731.8242.8646.9843.1140.04
Animal 5A500/250501/280500/250505/190519/231511/225500/250510/213502/200507/201
B5055.885037.6244.5144.035041.7639.8439.65
Animal 6A503/286514/241500/257610/286501/218504/175502/242506/227513/241508/218
B56.8646.8851.446.8843.5134.7248.2144.8646.9842.91
Animal 7A509/307503/227502/230503/230508/216502/201500/256503/250503/235508/216
B60.3145.1345.8245.7342.5240.0451.249.746.7242.52
TotalC53.50
± 1.63		49.11
± 1.35		46.74
± 1.98 *		42.88
± 1.27 *		41.10
± 1.62 *		38.94
± 1.65 *		49.00
± 1.22 *		45.22
± 1.01 *		44.25
± 1.01 *		40.36
± 0.74 *
SP
Animal 1A489/74505/101509/105500/125505/182507/174487/101507/109509/128507/122
B15.132020.632536.0434.3220.7421.525.1524.06
Animal 2A499/68505/101500/85507/105503/194504/150504/90501/106500/124500/125
B13.63201720.7138.5729.76178621.1624.825
Animal 3A501/7150/103504/100489/120509/128505/125503/101505/101509/128500/113
B14.1720.619.8424.5325.1524.7520.082025.1522.6
Animal 4A487/101500/97507/109500/113502/141500/141500/89505/101505/21500/114
B20.7419.421.522.628.0928.217.82023.9622.8
Animal 5A504/9052/101506/109500/120503/156500/120505/94506/112504/139500/110
B17.8620.1221.542431.012418.6120.1627.5822
Animal 6A500/99498/93500/99500/113506/135509/128503/116500/106507/109509/122
B19.818.6719.822.626.6825.1523.0621.221.523.97
Animal 7A501/94499/82503/99505/120501/136500/124500/120501/100505/125503/86
B18.7616.4319.6823.7627.1524.82419.9624.7517.1
TotalC17.16
± 1.07		19.32
± 0.53		20.00
± 0.58 *		23.31
± 0.55 *		30.38
± 1.93 *		27.28
± 1.42 *		20.15
± 0.84 *		21.15
± 0.53 *		24.70
± 0.68 *		22.50
± 0.98 *
A—cell number PGP/other substance studied. B—% of cells immunoreactive to substance studied. C—mean % ± SEM of cells immunoreactive to substance studied. The results were considered statistically significant at p < 0.05 and are marked with *.
Table 2. The number of neurons immunoreactive to vasoactive intestinal polypeptide (VIP), neuronal isoform of nitric oxide synthase (nNOS), vesicular acetylcholine transporter (VAChT), substance P (SP), and galanin (GAL) in the myenteric plexus (MP) and submucous plexus (SmP) of mouse jejunum in the control group (C), after the administration of lower (BPA1) and higher (BPA2) dose of BPA and lower (BPS1) and higher (BPS2) dose of BPS. The results were considered statistically significant at p < 0.05 and are marked with *.
Table 2. The number of neurons immunoreactive to vasoactive intestinal polypeptide (VIP), neuronal isoform of nitric oxide synthase (nNOS), vesicular acetylcholine transporter (VAChT), substance P (SP), and galanin (GAL) in the myenteric plexus (MP) and submucous plexus (SmP) of mouse jejunum in the control group (C), after the administration of lower (BPA1) and higher (BPA2) dose of BPA and lower (BPS1) and higher (BPS2) dose of BPS. The results were considered statistically significant at p < 0.05 and are marked with *.
nNOS
CBPA1BPA2BPS1BPS2
MP37.25 ± 1.2842.74 ± 1.42 *47.21 ± 3.67 *40.28 ± 0.53 *45.03 ± 1.54 *
SmP29.53 ± 0.3732.65 ± 0.82 *39.52 ± 1.29 *34.70 ± 0.58 *37.62 ± 0.99 *
VIP
CBPA1BPA2BPS1BPS2
MP30.56 ± 1.7740.66 ± 0.92 *45.52 ± 2.39 *33.02 ± 1.0139.98 ± 1.06 *
SmP29.59 ± 0.4234.98 ± 0.62 *39.81 ± 2.43 *30.88 ± 0.7533.21 ± 0.8 *
GAL
CBPA1BPA2BPS1BPS2
MP25.54 ± 0.8929.31 ± 1.06 *35.08 ± 1.36 *27.44 ± 0.7331.50 ± 1.64 *
SmP20.16 ± 0.9226.01 ± 1.08 *29.32 ± 0.96 *22.54 ± 2.5124.27 ± 0.98 *
VAChT
CBPA1BPA2BPS1BPS2
MP53.50 ± 1.6346.74 ± 1.98 *41.10 ± 1.62 *49.00 ± 1.22 *44.25 ± 1.01 *
SmP49.11 ± 1.3542.88 ± 1.27 *38.94 ± 1.65 *45.22 ± 1.01 *40.36 ± 0.74 *
SP
CBPA1BPA2BPS1BPS2
MP17.16 ± 1.0720.00 ± 0.58 *30.38 ± 1.93 *20.15 ± 0.84 *24.70 ± 0.68 *
SmP19.32 ± 0.5323.31 ± 0.55 *27.28 ± 1.42 *21.15 ± 0.53 *22.50 ± 0.98 *
Table 3. The list of primary and secondary antibodies.
Table 3. The list of primary and secondary antibodies.
Primary Antibodies
AntigenCodeSpeciesWorking DilutionSupplier
PGP 9.57863-2004Mouse1:1000BioRad, Hercules, CA, USA
VIP11428Rabbit1:4000Cappel, Aurora, OH, USA, 11428, working dilution 1:5000
SP8450-0505Rat1:1000BioRad
nNOSAB5380Rabbit1:2000Sigma-Aldrich, Saint Louis, MO, USA
GALT-5036Guinea pig1:2000Peninsula Labs, San Carlos, CA, USA
VAChTH-V006Rabbit1:2000Phoenix Pharmaceuticals, Burlingame, CA, USA
Secondary Antibodies Reagents
ReagentsWorking DilutionSupplier
Alexa fluor 488 donkey anti-mouse IgG1:1000ThermoFisher Scientific, Waltham, MA, USA
Alexa fluor 546 donkey anti-rabbit IgG1:1000ThermoFisher Scientific,
Alexa fluor 548 donkey anti-rat IgG1:1000ThermoFisher Scientific,
Alexa fluor 546 donkey anti-guinea pig IgG1:1000ThermoFisher Scientific,
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Makowska, K.; Gonkowski, S. Comparison of the Influence of Bisphenol A and Bisphenol S on the Enteric Nervous System of the Mouse Jejunum. Int. J. Mol. Sci. 2024, 25, 6941. https://doi.org/10.3390/ijms25136941

AMA Style

Makowska K, Gonkowski S. Comparison of the Influence of Bisphenol A and Bisphenol S on the Enteric Nervous System of the Mouse Jejunum. International Journal of Molecular Sciences. 2024; 25(13):6941. https://doi.org/10.3390/ijms25136941

Chicago/Turabian Style

Makowska, Krystyna, and Sławomir Gonkowski. 2024. "Comparison of the Influence of Bisphenol A and Bisphenol S on the Enteric Nervous System of the Mouse Jejunum" International Journal of Molecular Sciences 25, no. 13: 6941. https://doi.org/10.3390/ijms25136941

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop